| Literature DB >> 33041263 |
Jieun Yoon1, Hiroko Isoda1,2,3, Tomohiro Okura1,4.
Abstract
Not only does Japan has the world's longest healthy life expectancy, but also the world's longest average life span. This study investigated the effect of a novel dual-task (DT) exercise called "Synapsology" (SYNAP), developed as a game-like activity to improve older adults' physical and cognitive functions. Participants (n=24) with a mean age of 70.6 years (65-77 years) were randomly assigned to the SYNAP exercise group (SG, n=15) and the control group (CG, n=9). The SG participated in the DT intervention consisting of 60-minute sessions, twice a week, for 8 weeks. Physical function in timed-up-and-go had significant pre- and post- trial differences (P=0.017) in SG. In addition, cognitive function results in the a 25-hole trail-making peg test (P=0.004) and an oxidative stress marker (P=0.039) had a statistically significant difference within the SG. However, there were no significant differences in the physical and cognitive functions between SG and CG. In the study, older adults who participated in cognitive-motor DT intervention improved significantly with regard to motor ability and cognitive function results. Thus, a game-like DT exercise may help maintain the healthy life of older adults compared to no intervention.Entities:
Keywords: cognitive function; dual-task exercise; physical function; rock-paper-scissors (RPS) game
Year: 2020 PMID: 33041263 PMCID: PMC7732331 DOI: 10.18632/aging.103908
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Figure 1Basic movements of “Synapsology” (games combined with number counting, calculation, memory, problem-solving, visual color recognition, enumerating words, etc.). (A) First session: Rock, Paper, Scissors (RPS) game, (B) Second session: Pass the colored balls game. (See details in Supplementary Table 1).
Figure 2Flow diagram of participants in the trial.
Participant characteristics.
| Age (years) | 69.7 | ± | 3.3 | 65-76 | 71.9 | ± | 5.0 | 65-77 | 0.314 |
| Women (%) | 8 (53.3) | 4 (44.4) | 0.650† | ||||||
| Education (years) | 14.6 | ± | 3.0 | 9-19 | 11.9 | ± | 1.6 | 9-14 | 0.043 |
| Height (cm) | 161.5 | ± | 8.1 | 145.5-172.2 | 162.1 | ± | 7.6 | 147.2-168.6 | 0.865 |
| Body weight (kg) | 58.8 | ± | 9.6 | 47.2-71.0 | 60.6 | ± | 8.9 | 49.2-72.1 | 0.674 |
| Body mass index (kg/m2) | 22.5 | ± | 2.9 | 17.8-26.8 | 22.9 | ± | 1.8 | 21.1-25.5 | 0.710 |
| Systolic blood pressure (mmHg) | 137.9 | ± | 15.8 | 104-162 | 133.9 | ± | 25.3 | 90-161 | 0.674 |
| Diastolic blood pressure (mmHg) | 77.4 | ± | 8.5 | 63-93 | 78.1 | ± | 9.2 | 69-92 | 0.854 |
SG: Synapsology exercise group, CG: control group, SD: standard deviation, P-value: Student's t-test, †P-value: Chi-squared test
Physical and cognitive function by groups at baseline and follow-up.
| Physical function | |||||||||||||
| Timed up and go (sec.) | 4.90 | 4.42-5.90 | 4.55 | 3.89-5.86 | 0.51 | 0.017* | 4.89 | 4.23-7.97 | 5.00 | 4.22-6.90 | 0.03 | 0.779 | 0.114 |
| Five-times-sit-to stand movement test (sec.) | 5.89 | 4.59-7.96 | 5.47 | 4.55-8.67 | 0.10 | 0.950 | 5.73 | 4.95-6.64 | 5.54 | 4.79-7.88 | 0.17 | 0.678 | 0.778 |
| 5 m habitual walk test (sec.) | 3.08 | 2.80-4.70 | 3.15 | 2.87-4.70 | 0.07 | 0.925 | 3.15 | 2.60-4.71 | 3.16 | 2.60-3.75 | 0.44 | 0.271 | 0.257 |
| Cognitive function | |||||||||||||
| Trail making peg test (sec.) | 68.51 | 51.75-99.75 | 54.38 | 46.02-95.50 | 0.54 | 0.004* | 67.71 | 47.81-84.65 | 67.97 | 47.81-114.65 | 0.12 | 0.779 | 0.084 |
| d-ROMs (U CARR) | 394.00 | 307.00-476.00 | 389.00 | 285.00-486.00 | 0.28 | 0.039* | 417.00 | 309.00-594.00 | 426.00 | 358.00-594.00 | 0.06 | 0.889 | 0.570 |
| BDNF (ng/ml) | 188.27 | 157.79-248.27 | 202.31 | 136.82-259.89 | 0.01 | 0.790 | 190.53 | 107.15-253.92 | 166.50 | 116.18-239.89 | 0.59 | 0.069 | 0.148 |
SG: Synapsology exercise group, CG: control group, Effect size (d): Cohen's d=|0.2≤d<0.5|=small, |0.5≤d<0.8|=moderate, |0.8≤d|=large. P-value: Wilcoxon signed-rank test (pre- vs. post- trial), †P-value: Mann-Whitney u test (post Δ pre- trial). Asterisks show statistical significance at P<0.05.
Figure 3Trail-making peg test (TMPT, 25-hole peg test) by groups at baseline and follow-up. SG: Synapsology exercise group; CG: control group; Effect size (Cohen’s d): |0.2≤d<0.5|=small, |0.5≤d<0.8|=moderate, |0.8≤d|=large. Asterisk shows statistical significance at P<0.05.
Figure 4Two bioassays (d-ROMs and BDNF) by groups at the baseline and follow-up. SG: Synapsology exercise group; CG: control group. Effect size (Cohen’s d): |0.2≤d<0.5|=small, |0.5≤d<0.8|=moderate, |0.8≤d|=large. Asterisk shows statistical significance at P<0.05.
Figure 5Trail-making peg test (TMPT, 25-hole peg test) kit.